TCR

Quiénes somos

  • junio 28, 2024
    Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
  • diciembre 8, 2022
    Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
  • 5 de abril de 2022
    Administración de células T autólogas modificadas genéticamente para expresar receptores de células T reactivos contra neoantígenos en personas con cáncer metastásico